Endocarditis due to Kytococcus schroeteri: case report and review of the literature

Journal of Clinical Microbiology
Basma MnifAdnane Hammami

Abstract

We report the third case of endocarditis caused by the newly described micrococcal species Kytococcus schroeteri. A 49-year-old woman was admitted to the hospital with suspected prosthetic valve endocarditis. Five blood cultures and prosthetic valve cultures grew the same type of organism, initially identified as Micrococcus sp. Assignment to the genus Kytococcus was suggested by the arginine dihydrolase activity and resistance to oxacillin. After sequencing of the 16S rRNA genes, the isolate was recognized as K. schroeteri. The patient was treated first with vancomycin combined with gentamicin and later with pristinamycin and rifampin. Three cases of K. schroeteri endocarditis described within a short period of time might indicate a specific pathogenicity of this new species. The isolation of kytococci from normally sterile sites should not be overlooked.

References

Sep 1, 1979·Journal of Clinical Pathology·D C Old, G P McNeill
Oct 1, 1987·Archives of Dermatology·K M NordstromJ J Leyden
Jan 1, 1980·Journal of Neurosurgery·G R GreeneE L Fohz
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·C von EiffG Peters
Aug 1, 1996·The Pediatric Infectious Disease Journal·C von EiffG Peters
Oct 1, 1995·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H SeifertF Perdreau-Remington
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Oct 4, 2002·International Journal of Systematic and Evolutionary Microbiology·Karsten BeckerChristof von Eiff
Jan 17, 2004·Emerging Infectious Diseases·Karsten BeckerChristof von Eiff
Feb 18, 2005·Emerging Infectious Diseases·Cécile Le BrunOlivier Gaillot
Jul 26, 2005·The Journal of Infection·I MohammediJ Etienne

❮ Previous
Next ❯

Citations

Jan 13, 2010·Clinical Microbiology Reviews·Graeme N Forrest, Kimberly Tamura
Jul 11, 2008·Journal of Clinical Microbiology·Karsten BeckerChristof von Eiff
Dec 14, 2011·Journal of Clinical Microbiology·Ola BlennowVolkan Ozenci
Jan 1, 2010·BMJ Case Reports·Taher YousriSteve Langley
Feb 2, 2008·Wiener klinische Wochenschrift·Christian AepinusMichael Petzsch
Jun 13, 2015·Case Reports in Infectious Diseases·Akshay AmaraneniDeepak Garg
Sep 25, 2012·Journal of Medical Microbiology·Frieder SchaumburgKarsten Becker
Oct 9, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Aurelie RenvoiseAlberto Riberi
Nov 18, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Sarah JourdainAnne Vergison
Oct 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P C Y WooK-Y Yuen
Mar 24, 2018·The Pediatric Infectious Disease Journal·Banu BayraktarErcüment Petmezci
Feb 13, 2018·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Ines BoujelbenAdnane Hammami
Mar 5, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·D Chaudhary, S N Finkle
Apr 4, 2021·Infectious Disease Reports·Shelly Bagelman, Gunda Zvigule-Neidere
Aug 28, 2021·Medicina·Kyoung Ree LimSoo-Youn Moon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.